Cash Cash Equivalents - Abbott Laboratories (NYSE:ABT) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 106.89 USD -0.65%

Updated:

Abbott Laboratories
Cash & Cash Equivalents

Last Value

3-Years CAGR

5-Years CAGR

Quarterly

Annual

|

Adjust for Inflation

Abbott Laboratories
Cash & Cash Equivalents Peer Comparison

BDX

BSX

EW

SYK

ISRG

Company		Cash & Cash Equivalents	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Abbott Laboratories NYSE:ABT	Cash & Cash Equivalents $6.9B	CAGR 3-Years -5%	CAGR 5-Years 18%	CAGR 10-Years 13%
	Becton Dickinson and Co NYSE:BDX	Cash & Cash Equivalents $1.2B	CAGR 3-Years -29%	CAGR 5-Years 5%	CAGR 10-Years -3%
	Boston Scientific Corp NYSE:BSX	Cash & Cash Equivalents $865m	CAGR 3-Years -21%	CAGR 5-Years 43%	CAGR 10-Years 15%
	Edwards Lifesciences Corp NYSE:EW	Cash & Cash Equivalents $1.1B	CAGR 3-Years -1%	CAGR 5-Years 10%	CAGR 10-Years 11%
	Stryker Corp NYSE:SYK	Cash & Cash Equivalents $2.9B	CAGR 3-Years 0%	CAGR 5-Years -4%	CAGR 10-Years 8%
	Intuitive Surgical Inc NASDAQ:ISRG	Cash & Cash Equivalents $2.8B	CAGR 3-Years 25%	CAGR 5-Years 26%	CAGR 10-Years 13%

See Also

Based on the financial report for Mar 31, 2024, Abbott Laboratories's Cash & Cash Equivalents amounts to 6.9B USD.

Over the last year, the Cash & Cash Equivalents growth was -25%. The average annual Cash & Cash Equivalents growth rates for Abbott Laboratories have been -5% over the past three years , 18% over the past five years , and 13% over the past ten years .

Join more than 131,100+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.